Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.
Rosanna DammaccoSilvana GuerrieroGiovanni AlessioFranco DammaccoPublished in: International ophthalmology (2021)
The level of evidence for most of the drug reactions described herein is restricted to the "likely" or "possible" rather than to the "certain" category. However, the lack of biomarkers indicative of the potential risk of ocular ADRs hinders their prevention and emphasizes the need for an accurate risk vs. benefit assessment of these therapies for each patient.